Rubicon Research IPO 2025: Price Band, Listing Date, Subscription Updates & Expert Analysis
The much-awaited Rubicon Research IPO 2025 has captured the attention of investors across India. The company, known for its strong pharmaceutical formulations and global research collaborations, has announced the IPO details, attracting significant interest from retail and institutional investors alike.
Rubicon Research IPO Price Band and Issue Details
The initial public offering (IPO) of Rubicon Research has been priced in the range of ₹700–₹730 per share. The IPO opens for subscription on October 20, 2025 and closes on October 24, 2025. Investors can subscribe through their broker accounts or banking platforms that facilitate IPO subscriptions.
Listing Date and Stock Exchanges
Rubicon Research IPO is expected to be listed on the BSE and NSE on October 31, 2025. Analysts suggest that the stock may see strong opening momentum due to robust demand in both retail and institutional segments.
Subscription Status and Investor Interest
As of the latest update, the IPO has seen oversubscription in the retail segment, reflecting strong investor confidence in Rubicon Research’s growth prospects. Institutional investors have also shown keen interest, indicating potential for a solid debut on listing day.
Company Background and Financial Highlights
Rubicon Research is a leading pharmaceutical and life sciences company with a strong focus on research and innovation. The company has consistently delivered high-quality formulations and has expanded its reach internationally. For FY 2024–25, Rubicon reported a revenue of approximately ₹1,200 crore with a steady profit margin, making it one of the most attractive IPOs in the healthcare sector this year.
Expert Analysis and Investment Tips
Experts suggest that investors consider the long-term potential of Rubicon Research rather than short-term listing gains. With a growing pipeline of products and research partnerships, the company is well-positioned for sustainable growth. Investors are advised to check allotment updates and avoid oversubscription pitfalls.
How to Apply for Rubicon Research IPO
Investors can apply online through their demat accounts using ASBA (Application Supported by Blocked Amount) or through the IPO facility provided by banks. Ensure you have verified KYC details and sufficient funds in your account before applying.
Conclusion
The Rubicon Research IPO 2025 offers a promising investment opportunity for both retail and institutional investors. With strong fundamentals, clear growth prospects, and a robust market position, the IPO is expected to attract significant attention in the coming days. Stay updated with the latest subscription status and allotment news to make informed investment decisions.